KMT2A and leukemia: A report by Gale et al demonstrated that genomic fusion sequences are present and detectable in neonatal blood spots of patients who went on to develop MLL rearranged infant leukemia [14], illustrating that preleukemic clones can be detected at birth in patients that present with leukemia early in life.